COVID-19 vaccines versus pediatric hospitalization.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 36801010.
- Also identified by DOI 10.1016/j.xcrm.2023.100936 and PMC identifier 9868379.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Vaccine effectiveness of BNT162b2 and CoronaVac against COVID-19-associated hospitalization and moderate-to-severe disease due to SARS-CoV-2 Omicron BA.2 is studied from the 1.36 million doses administered to 766,601 of 953,400 children aged 3-11 years and adolescents aged 12-18 years in Hong Kong as of April 2022. These vaccines confer substantial protection.
Medical subject headings
- COVID-19 Vaccines
- COVID-19